A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
Clinical Trials Arena on MSN14h
GenSight’s Optic Neuropathy gene therapy sustains efficacy over five yearsThe five-year trial saw patients who received a single injection of Lumevoq sustaining clinical recovery in a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback